Prevalence of genital tract infections among adolescents attending genitourinary medicine clinics
| Infection | % (No) | 95% CI |
|---|---|---|
| *Includes two girls who did not give swabs because of painful herpes lesions. | ||
| †HPV screening started after 3 months. | ||
| HSV-2 (antibodies) | 4.3 (116) | 1.4 to 9.8 |
| HSV-1/HSV-2 (viral shedding) | 3.9 (127)* | 1.3 to 8.9 |
| HPV DNA | 64.4 (90)† | 53.7 to 74.3 |
| Ano-genital warts | 16.9 (89) | 9.8 to 26.3 |
| Chlamydia | 26.8 (127) | 19.3 to 35.4 |
| Gonorrhoea | 1.6 (127) | 0.2 to 5.6 |
| Candidiasis | 6.3 (127) | 0.3 to 12.0 |
| Bacterial vaginosis | 33.9 (127) | 25.7 to 42.8 |
| Trichomoniasis | 3.1 (127) | 0.9 to 7.9 |
| Syphilis | 0.0 (127) | 0.0 to 2.9 |
| No infection | 15.6 (90) | 8.8 to 24.7 |
| Single infection | 43.3 (90) | 32.9 to 54.2 |
| Two or more infections | 44.1 (90) | 34.0 to 55.3 |